Artimplant

ARTIMPLANT THREE - MONTH REPORT 2013

5/30/2013 8:30 AM EST

• Net revenue amounted to SEK 4.4 million (6.8)

• The net loss totaled SEK 4.7 million (2.3), a deterioration of SEK 2.4 million due to the fall in revenue.

• Earnings per stock unit amounted to SEK -0.01 (-0.01).

• Artimplant prolongs its funding agreement regarding costs for trials in USA and recovers previous legal costs of SEK 5 million.

• Artimplant has requested arbitration in the insurance...

Artimplant and Tiller signs an agreement

5/30/2013 5:00 AM EST

Artimplant AB (publ) and Tiller International Capital have today entered into an agreement regarding a Sales, Marketing and Distribution Agreement which will gives Tiller the exclusive right to sell, market and distribute all Artimplant´s products outside Europe and non exclusively within Europe.

The detailed operational procedures are expected to be completed within the next four weeks.

The current sales efforts...

Artimplant postpones Annual General Meeting until June 27, 2013 and publishes th...

4/29/2013 7:53 AM EST

The Board decided to put back the Annual General Meeting 2013 from May 30 to June 27, 2013. The ongoing company evaluation work by the Board regarding the structure of the company and ways to finance the company continues

The company publishes the Annual report 2012 on the company web page;

http://www.artimplant.com/investors-media/arsredovisningar.html. The report will only be published in Swedish. The Annual...

Artimplant postpones Annual General Meeting and Interim Report

4/4/2013 9:00 AM EST

The Board has decided to put back the Annual General Meeting and the first Interim Report for 2013 from May 7 to May 30, 2013. The decision is related to the ongoing company evaluation work by the Board regarding the structure of the company and ways to finance the company into a profitable and competitive business of the future.

The Board intends to present the outcome of the work at the upcoming AGM on May 30,...

Anders Cedronius, Chairman of the Board, has announced that he will not be avail...

3/26/2013 6:00 AM EST

Västra Frölunda, March 26, 2013

Lars Peterson
Board Member and Chairman of the Nomination Committee

For further information, please contact:
Lars Peterson
E-mail:
Telephone: +46 702 91 41 86

Further information is available at www.artimplant.com where you can also subscribe to future press releases;...

ARTIMPLANT YEAR-END-REPORT JANUARY – DECEMBER 2012

2/27/2013 2:55 AM EST

· Net revenue increased by 15 percentage points and amounted to SEK 21.1 million (18.3).
· The net loss after tax totaled SEK 16.5 million (17.9). This represented an improvement in result of SEK 1.4 million compared to the corresponding period the previous year.
· Earnings per stock unit amounted to SEK -0.03 (-0.15).
· The aim of achieving a positive cash flow before changes in working capital on a monthly...

Artimplant prolongs its funding agreement regarding costs for trials in USA, rec...

2/25/2013 11:25 AM EST

Artimplant and the two insurance companies involved and the insurance broker have prolonged the funding agreement entered into during the summer of 2012 which purpose is to fund Artimplant’s costs for the trails in USA until a final solution is reached to divide the liability amongst the parties.

Further, the parties have agreed that Artimplant’s costs for the trails incurred before the funding agreement was signed...

Artimplant postpones Year-End Report

1/31/2013 5:00 AM EST

The Board of Directors has decided to postpone the publication of Artimplant's Year-End Report until February 27, 2013. The original publication date was February 1, 2013.
The reason for the change is the ongoing complaints in the USA and the related insurance situation. As stated previously, it is Artimplant's understanding that there is perfectly adequate insurance cover for the costs attributable to the...

Artimplant USA Medical Advisory Board

11/27/2012 7:00 AM EST

Artimplant has formed a Medical Advisory Board (MAB) in the US comprising leading surgeons with a diversity of expertise in the field of orthopedic and podiatric medicine. The MAB will provide feedback and guidance to Artimplant and develop knowledge of Artimplant's products.

The members of the Artimplant USA Medical Advisory Board (MAB) are: Eric Giza, MD, Edward Diao, MD, Joseph M. Berman, MD, Janos P. Ertl MD,...

Election Committee 2013

11/2/2012 3:45 AM EST

It was decided at the Artimplant Annual General Meeting on May 3, 2012 that the Election Committee would comprise the Chairman of the Board of Directors plus three members appointed by the three largest stockholders, according to voting power, as of September 30, 2012.
The composition of the Election Committee must be announced no later than six months prior to the Annual General Meeting.

Up to the 2013 Annual...

Releases - Artimplant

Found press releases